Digestive Disease Week 2011: highlights of clinical and preclinical research on Barrett's esophagus and associated esophageal adenocarcinoma

被引：2

作者：

van de Winkel, A. ^{[1
]}

Massl, R. ^{[1
]}

Kuipers, E. J. ^{[1
,2
]}

van der Laan, L. J. W. ^{[3
]}

Peppelenbosch, M. P. ^{[1
]}

机构：

[1] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands

[2] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands

[3] Erasmus MC, Dept Surg, Rotterdam, Netherlands

来源：

DISEASES OF THE ESOPHAGUS | 2013年 / 26卷 / 02期

关键词：

Barrett's esophagus; diagnostics; esophageal adenocarcinoma; etiology; surveillance; treatment and prevention; HIGH-GRADE DYSPLASIA; VITAMIN-D; RADIOFREQUENCY ABLATION; CELL-LINES; ADIPOSE-TISSUE; GERD PATIENTS; RISK; PATHWAY; MODEL; MULTICENTER;

D O I：

10.1111/j.1442-2050.2012.01340.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Clinicians and basic researchers worldwide convened at the annual Digestive Disease Week where the latest research in the field of gastroenterology and hepatology is presented. In this report, the highlights of the convention on the field of Barrett's esophagus (BE) and associated esophageal adenocarcinoma (EAC) are summarized. New clinical and preclinical developments in etiology, diagnosis, surveillance, and prevention and therapy of BE and EAC in respect to current knowledge are reflected. We also discuss the relevance and impact of these findings on the future of BE and EAC research.

引用

页码：130 / 140

页数：11

共 67 条

[1] Serum 25(OH)-Vitamin D concentration and risk of esophageal squamous dysplasia [J].

Abnet, Christian C. ;

Chen, Wen ;

Dawsey, Sanford M. ;

Wei, Wen-Qiang ;

Roth, Mark J. ;

Liu, Bing ;

Lu, Ning ;

Taylor, Philip R. ;

Qiao, You-Lin .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (09) :1889-1893

[2]

Ahmad J, 2011, GASTROENTEROLOGY, V140, pS998

[3]

Akiyama J, 2011, GASTROENTEROLOGY, V140, pS179

[4]

BANSAL A, 2011, GASTROENTEROLOGY S1, V140, pS306

[5]

Bhutta HY, 2011, GASTROENTEROLOGY, V140, pS166

[6] Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus [J].

Buttar, NS ;

Wang, KK ;

Leontovich, O ;

Westcott, JY ;

Pacifico, RJ ;

Anderson, MA ;

Krishnadath, KK ;

Lutzke, LS ;

Burgart, LJ .

GASTROENTEROLOGY, 2002, 122 (04) :1101-1112

[7]

Cadman L, 2011, GASTROENTEROLOGY, V140, pS178

[8] Current status of Barrett's esophagus research in Asia [J].

Chang, Chi-Yang ;

Cook, Michael B. ;

Lee, Yi-Chia ;

Lin, Jaw-Town ;

Ando, Takafumi ;

Bhatia, Shobna ;

Chow, Wong-Ho ;

El-Omar, Emad M. ;

Goto, Hidemi ;

Li, Yang-Qing ;

McColl, Kenneth ;

Reddy, Nageshwar ;

Rhee, Poong-Lyul ;

Sharma, Prateek ;

Sung, Joseph J-Y ;

Ghoshal, Uday ;

Wong, Jennie Y-Y ;

Wu, Justin C-Y ;

Zhang, Jun ;

Ho, Khek-Yu .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (02) :240-246

[9] Protective association of aspirin/NSAIDs and esophageal cancer: A systematic review and meta-analysis [J].

Corley, DA ;

Kerlikowske, K ;

Verma, R ;

Buffler, P .

GASTROENTEROLOGY, 2003, 124 (01) :47-56

[10] Abdominal obesity and the risk of esophageal and gastric cardia carcinomas [J].

Corley, Douglas A. ;

Kubo, Ai ;

Zhao, Wei .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (02) :352-358

← 1 2 3 4 5 6 7 →